Cargando…

Tenofovir-induced renal and bone toxicity: report of two cases and literature review

Tenofovir Disoproxil Fumarate (TDF) is one of the drugs in the initial first-line antiretroviral regimen for the treatment of hepatitis B and HIV infections. Despite its effectiveness and few adverse effects, it is related to renal and bone toxicity. We described two cases of HIV-positive middle-age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fioroti, Carlos Eduardo Andrade, Distenhreft, Jesiree Iglésias Quadros, Paulino, Bruna Bastos, Lacchine, Kamilla, Ramos, Danilo Rodrigues, Seguro, Antonio Carlos, Luchi, Weverton Machado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical de São Paulo 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845457/ https://www.ncbi.nlm.nih.gov/pubmed/35170711 http://dx.doi.org/10.1590/S1678-9946202264010

Ejemplares similares

The role of urea-induced osmotic diuresis and hypernatremia in a critically ill patient: case report and literature review
por: Distenhreft, Jesiree Iglésias Quadros, et al.
Publicado: (2019)

A physiology-based approach to a patient with hyperkalemic renal tubular acidosis
por: Menegussi, Juliana, et al.
Publicado: (2018)

Atypical presentation of familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a patient with a new claudin-16 gene mutation
por: Vianna, Júlia Guasti P., et al.
Publicado: (2019)

The “new normal” osmotic threshold: Osmostat reset
por: Rigueto, Larissa G., et al.
Publicado: (2022)

N-acetylcysteine protects against star fruit-induced acute kidney injury
por: Shimizu, Maria Heloisa Massola, et al.
Publicado: (2016)

Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
por: Walti, Laura N, et al.
Publicado: (2018)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

Vitamin D Deficiency Aggravates Nephrotoxicity, Hypertension and Dyslipidemia Caused by Tenofovir: Role of Oxidative Stress and Renin-Angiotensin System
por: Canale, Daniele, et al.
Publicado: (2014)

Investigating Organ Toxicity Profile of Tenofovir and Tenofovir Nanoparticle on the Liver and Kidney: Experimental Animal Study
por: Peter, Aniekan Imo, et al.
Publicado: (2018)

Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana
por: Nartey, Edmund T., et al.
Publicado: (2019)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir
por: Patil, Rashmee, et al.
Publicado: (2015)

Tenofovir Renal Proximal Tubular Toxicity Is Regulated By OAT1 and MRP4 Transporters
por: Kohler, James J., et al.
Publicado: (2011)

Fetal deaths in Brazil: a systematic review
por: Barbeiro, Fernanda Morena dos Santos, et al.
Publicado: (2015)

Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease
por: Beraldo, Juliana Isa, et al.
Publicado: (2019)

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
por: Wassner, Chanie, et al.
Publicado: (2020)

Renal mitochondrial toxicity: effects of thymidine analogues and tenofovir disoproxil fumarate in African people living with HIV
por: Hunt, Matthew, et al.
Publicado: (2022)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Ganciclovir–tenofovir interaction leading to tenofovir-induced nephrotoxicity
por: Soanker, Radhika, et al.
Publicado: (2014)

Population pharmacokinetics of tenofovir and tenofovir‐diphosphate in healthy women
por: Burns, Rebecca N., et al.
Publicado: (2015)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials
por: Gupta, Samir K., et al.
Publicado: (2019)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
por: Lalley-Chareczko, Linden, et al.
Publicado: (2020)

N-Acetylcysteine Protects Rats with Chronic Renal Failure from Gadolinium-Chelate Nephrotoxicity
por: Pereira, Leonardo Victor Barbosa, et al.
Publicado: (2012)

Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya
por: Karoney, Mercy Jelagat, et al.
Publicado: (2022)

Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial
por: Silveira, Marcelo Augusto Duarte, et al.
Publicado: (2019)

An overview of tenofovir and renal disease for the HIV-treating clinician
por: Venter, Willem D.F., et al.
Publicado: (2018)

Review of tenofovir-emtricitabine
por: Masho, Saba Woldemichael, et al.
Publicado: (2007)

Chemoenzymatic Synthesis of Tenofovir
por: Zdun, Beata, et al.
Publicado: (2023)

A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs
por: Zane, Doris, et al.
Publicado: (2021)

Distal Renal Tubular Acidosis Associated with Autoimmune Diseases: Reports of 3 Cases and Review of Mechanisms
por: Silveira, Marcelo Augusto Duarte, et al.
Publicado: (2022)

Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques
por: Dobard, Charles W, et al.
Publicado: (2015)

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
por: Funderburg, Nicholas T., et al.
Publicado: (2016)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
por: Michienzi, Sarah M, et al.
Publicado: (2021)

Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients
por: Seo, Jun-Won, et al.
Publicado: (2020)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
por: Johnson, Kelly A, et al.
Publicado: (2021)

EFFECT OF PASTEURIZATION ON THE ANTIOXIDANT AND OXIDANT PROPERTIES OF HUMAN MILK
por: Lorençoni, Mariane Fioroti, et al.
Publicado: (2020)

Hemodiafiltration Decreases Serum Levels of Inflammatory Mediators in Severe Leptospirosis: A Prospective Study
por: Cleto, Sérgio Aparecido, et al.
Publicado: (2016)

Tenofovir disoproxil fumarate may not cause renal and bone toxicity in chronic hepatitis B patients: a retrospective cross-sectional study
por: GÜNER, Rahmet, et al.
Publicado: (2019)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
por: Hill, Andrew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mu85pevqjo9ul9h5ob6kc8gne5